MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    All that emerge is not Lupus

    M. Spitz, S. de Souza, I. Sodré, B. Panichelli (Rio de Janeiro, Brazil)

    Objective: The aim of this article is to report a rare case of Huntington's disease (HD) in a patient with chorea and previous diagnosis of…
  • 2022 International Congress

    Outcome prediction using fractional anisotropy map immediately just after magnetic resonance-guided focused ultrasound surgery for essential tremor

    K. Iijima, H. Yokota, M. Nakano, T. Yamaguchi, F. Maki, S. Hino, M. Takasaki, H. Iwamuro, T. Uno (Kangawa, Japan)

    Objective: To investigate whether fractional anisotropy (FA) value can predict the outcome of magnetic resonance-guided focused ultrasound (MRgFUS) for essential tremor. Background: MRgFUS achieves its…
  • 2022 International Congress

    Fingolimod-responsive complex hyperkinetic movement disorder in neuromyelitis optica spectrum disorder

    RE. Cortes, JA. Vatanagul, G. Saranza (Cebu, Philippines)

    Objective: Highlight a complex hyperkinetic movement disorder in Neuromyelitis optica spectrum disorder exacerbation with remission on fingolimod therapy. Background: Neuromyelitis optica spectrum disorder (NMOSD) can…
  • 2022 International Congress

    Sarcopenia Screening with Limb Circumference and Impacts of Sarcopenia in Parkinson’s disease

    SJ. Kim, YJ. Jeong, SM. Cheon ()

    Objective: In this study, we evaluated limb circumference as sarcopenia screening tool in PD and comprehensively investigated the impacts of sarcopenia in PD. Background: Sarcopenia…
  • 2022 International Congress

    Safinamide as an adjunct to Levodopa Therapy in Asian and Caucasian Patients with Parkinson’s Disease and Motor Fluctuations: A post-hoc Analysis of the SETTLE study

    R. Bhidayasiri, T. Ishida, RE. Husni, T. Kamei, I. Suzuki, SL. Wu, JW. Cho (Bangkok, Thailand)

    Objective: This study evaluated the efficacy and safety outcomes of safinamide as a levodopa adjunct therapy in Asian and Caucasian patients with Parkinson’s disease. Background:…
  • 2022 International Congress

    Epidemiologic And Clinical Features Of Psychiatric Disorders In Patients With Parkinson’s Disease – A Retrospective Cohort Study

    O. Koniashvili, G. Khachiashvili, L. Gabunia (Tbilisi, Georgia)

    Objective: We aimed to assess the average duration of Parkinson's disease at the time patient was diagnosed with specific neuropsychiatric disturbance, to study their prevalence…
  • 2022 International Congress

    Abnormal fractional anisotropy of the tremor network in tremor dominant Parkinson’s disease and Essential tremor plus syndrome

    P. Pal, S. Prasad, R. Bharath, J. Saini (Bangalore, India)

    Objective: To evaluate alterations in fractional anisotropy (FA) of the basal ganglia-thalamocortical (BGTC) and cerebello-thalamocortical (CTC) network in tremor dominant Parkinson’s disease (TDPD) and essential…
  • 2022 International Congress

    Neuroprotective effect of Boswellia dalzielii extracts in 6-hydroxydopamine-lesioned rat model of Parkinson’s disease

    GL. Ndji Otto, H. Adjia, JP. Mingoas Kilekoung (Bertoua, Cameroon)

    Objective: To evaluate the possible protective effects of Boswellia dalzielii in animal model of Parkinson Disease (PD) induced by 6-hydroxydopamine (6-OHDA) injection in the striatum…
  • 2022 International Congress

    Predictive factors for a favorable STN-DBS outcome in Parkinson’s Disease: the role of axial symptoms

    C. Ledda, C. Artusi, G. Imbalzano, M. Bozzali, M. Rizzone, A. Romagnolo, M. Zibetti, L. Lopiano (Turin, Italy)

    Objective: We sought to identify and weight clinical and demographic factors predicting bilateral STN-DBS outcomes. Background: DBS is an established therapeutic option for treating PD…
  • 2022 International Congress

    Relationship between falls and motor state in Parkinson’s disease patients with motor fluctuations

    Y. Okuma (Izunokuni, Japan)

    Objective: To elucidate in which motor state Parkinson’s disease (PD) patients with motor fluctuations fall. Background: Recurrent falls are a disabling feature of PD and…
  • 1
  • 2
  • 3
  • …
  • 153
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley